MedPath

Comparison of Effect of Adalimumab versus Hyaluronic Acid in Knee Osteoarthritis

Phase 4
Recruiting
Conditions
Primary Osteoarthritis of the Knee
Registration Number
CTRI/2018/09/015662
Lead Sponsor
All India Institute of Medical Sciences
Brief Summary

Although an Intra - Articular Injection of Hyaluronic Acid is commonly used for the treatment of Osteoarthritis of the knee, Adalimumab owing to its ability to downregulate the expression of pro - inflammatory cytokines and rate of synthesis of metalloproteinases has shown good results in inflammatory conditions. However, few attempts have been made to improve the treatment of patients with Knee OA by Intra -Articular Adalimumab.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
19
Inclusion Criteria
  • Diagnosis of Knee OA as per 2016 ACR Revised Criteria for Early Diagnosis of Knee OA 2.
  • Unilateral Primary OA of Grade 2 or Grade 3 on Kellgren Lawrence Scale 3.
  • Pain Score >4 on VAS( Visual Analogue Scale) within the past one month 4.
  • Lack of efficacy of previous treatment with Diclofenac at a dose of 75mg/day.
Exclusion Criteria
    1. Previous treatment with TNF inhibitors 2. Previous Intra.
  • Articular treatment within 3 months 3.Previous Knee Surgery 4. History of tumor or serious Infection 5. Pregnancy 6. Lactation 7. Cognitive Impairment 8. Previous history of trauma to the knee.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To Compare the Effect of a Single Ultrasound - Guided Intra - Articular Injection of Adalirec) mumab with a Single Ultrasound Guided Intra -Articular Injection of Hyaluronic Acid on Pain using VAS4 weeks and 12 weeks post injection
Secondary Outcome Measures
NameTimeMethod
To Compare the Effect of a Single Ultrasound - Guided Intra - Articular Injection of Adalimumab with a Single Ultrasound Guided Intra -Articular Injection of Hyaluronic Acid on Pain, other Symptoms, Function in Daily Living(ADL), Function in Sport and Recreation(Sport/Rec) using KOOS Scale4 weeks and 12 weeks post injection

Trial Locations

Locations (1)

AIIMS, New Delhi

🇮🇳

West, DELHI, India

AIIMS, New Delhi
🇮🇳West, DELHI, India
Dr Abhimanyu Vasudeva
Principal investigator
9910185126
abhimanyu.vmmc@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.